100% of cells have LD localization, i.e., there are both LD and cytoplasmic pools of the enzymes. To quantify the percent of expressed protein present on LDs in comparison to the cytoplasm, we used fluorescence intensity 
line plots, which showed that the LD:cytoplasm ratio of the PNPLA4-3 and PNPLA4-5 fusions were significantly higher than PNPLA4. Oddly, the fusion construct with the Cterminal domain of ATGL, PNPLA4-ATGL, did not localize to LDs suggesting that this protein may be misfolded, or the putative LTM may be masked by PNPLA4 or not presented in the appropriate structural context. Alterations in the Basic Patch LTM of PNPLA5 Abolish LD Targeting The above results suggest that the conserved arginines or positively charged amino acids from residues 358361 are important for LD association. To determine if any particular arginine was important, we made more conservative alterations by replacing all combinations 21505263 of the arginines within residues 358361 with alanines. These changes were made in fulllength GFP-tagged PNPLA5, which was expressed in HeLa cells previously fed OA to form LDs. The results showed that no particular arginine was critical but that removal of any one incrementally reduced LD association, such that alteration of all three arginines reduced LD association to background levels. As a more sensitive measure of LD localization, differences in subcellular localization were measured by the ratio between the fluorescence intensity at the LD surface and the cytoplasm. These fluorescence intensity line plots confirmed that only constructs with three positively charged residues had a similar LD:cytoplasm ratio distribution compared to wildtype PNPLA5. These results were consistent regardless of the type of neutral lipid dye used, LipidTox, Oil Red O, or BODIPY. To better determine the fraction of total PNPLA5 associated with LDs, we isolated LDs from OA-fed cells using sucrose gradients and measured the distribution of PNPLA5 found in cytoplasmic vs. LD fractions by Western blot. We found that,27% of the total PNPLA5 was found in the LD fraction. Moreover, this approach verified our in vivo results by showing that PNPLA5, the mutant lacking all three arginines, was not found in the LD fraction. To determine if charge itself or some other feature of the RSRRLV basic patch residues is important for LD targeting, two of the arginines within this motif were changed to lysines, thus generating PNPLA5. The results showed that PNPLA5 localized to LDs to the same extent as wild type PNPLA5. PKA phosphorylation affects the localization of HSL and CGI58, while AMP Kinase modifies the activity of ATGL. However, mutating a putative AMP kinase phosphorylation site had no effect on the localization of PNPLA5. We conclude that the positively charged residues are necessary for PNPLA5 MedChemExpress GSK-429286A interaction with LDs. Identification of a Basic Patch LTM in PNPLA5 PNPLA5 homologs in various species exhibit significant sequence conservation within amino acids 340364. Two sequences in particular were interesting: a proline knot-like motif that has similarity to a LD targeting domain of oleosin and the core proteins of 11404282 hepatitis C virus and GB Virus-B, and an arginine-containing motif that could serve as a basic patch for binding to negatively charged phospholipids on the LD surface. To determine if these are important for LD association, site-directed mutagenesis was performed on these motifs within full-length GFP-tagged PNPLA5: wild type PNPLA5 was mut
